Victory Capital Management Inc. lifted its holdings in Masimo Co. (NASDAQ:MASI) by 36.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 410,400 shares of the medical equipment provider’s stock after buying an additional 109,470 shares during the quarter. Victory Capital Management Inc.’s holdings in Masimo were worth $34,802,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in MASI. DekaBank Deutsche Girozentrale increased its stake in shares of Masimo by 78.3% in the third quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after acquiring an additional 925 shares during the period. Advisor Group Inc. increased its stake in shares of Masimo by 38.4% in the second quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after acquiring an additional 655 shares during the period. Intellectus Partners LLC acquired a new stake in shares of Masimo in the second quarter worth $237,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Masimo by 39.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock worth $239,000 after acquiring an additional 802 shares during the period. Finally, Shelton Capital Management acquired a new stake in shares of Masimo in the second quarter worth $269,000. Hedge funds and other institutional investors own 82.57% of the company’s stock.

In related news, Director Sanford Fitch sold 2,000 shares of the stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $90.00, for a total transaction of $180,000.00. Following the sale, the director now directly owns 70,249 shares of the company’s stock, valued at $6,322,410. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Yongsam Lee sold 10,000 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $92.95, for a total transaction of $929,500.00. Following the sale, the executive vice president now directly owns 79,000 shares in the company, valued at $7,343,050. The disclosure for this sale can be found here. Insiders have sold 48,098 shares of company stock worth $4,315,261 over the last three months. 16.60% of the stock is currently owned by insiders.

A number of research firms have recently weighed in on MASI. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday. BidaskClub lowered shares of Masimo from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. Masimo currently has a consensus rating of “Hold” and an average target price of $97.17.

Shares of Masimo Co. (NASDAQ MASI) opened at $83.47 on Friday. Masimo Co. has a twelve month low of $75.06 and a twelve month high of $104.71. The stock has a market cap of $4,240.13, a price-to-earnings ratio of 13.21, a P/E/G ratio of 3.12 and a beta of 0.85.

TRADEMARK VIOLATION WARNING: This piece was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2018/02/10/victory-capital-management-inc-grows-stake-in-masimo-co-masi.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.